| pubmed-article:11054389 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11054389 | lifeskim:mentions | umls-concept:C0241910 | lld:lifeskim |
| pubmed-article:11054389 | lifeskim:mentions | umls-concept:C0054201 | lld:lifeskim |
| pubmed-article:11054389 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:11054389 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:11054389 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11054389 | pubmed:dateCreated | 2000-11-27 | lld:pubmed |
| pubmed-article:11054389 | pubmed:abstractText | Budesonide has a high hepatic first-pass clearance and metabolites virtually devoid of glucocorticoid activity. Our goals were to assess budesonide in patients with treatment-dependent autoimmune hepatitis and to determine if efficacy and safety justified a controlled trial. | lld:pubmed |
| pubmed-article:11054389 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11054389 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11054389 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11054389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11054389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11054389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11054389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11054389 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11054389 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11054389 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11054389 | pubmed:issn | 0016-5085 | lld:pubmed |
| pubmed-article:11054389 | pubmed:author | pubmed-author:LindorK DKD | lld:pubmed |
| pubmed-article:11054389 | pubmed:author | pubmed-author:CzajaA JAJ | lld:pubmed |
| pubmed-article:11054389 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11054389 | pubmed:volume | 119 | lld:pubmed |
| pubmed-article:11054389 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11054389 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11054389 | pubmed:pagination | 1312-6 | lld:pubmed |
| pubmed-article:11054389 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:meshHeading | pubmed-meshheading:11054389... | lld:pubmed |
| pubmed-article:11054389 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11054389 | pubmed:articleTitle | Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. | lld:pubmed |
| pubmed-article:11054389 | pubmed:affiliation | Division of Gastroenterology and Hepatology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA. czaja.albert@mayo.edu | lld:pubmed |
| pubmed-article:11054389 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11054389 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11054389 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11054389 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11054389 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11054389 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11054389 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11054389 | lld:pubmed |
